Eun Young Lee - 29 Jan 2026 Form 4 Insider Report for Nexentis Technologies Inc. (NXTS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
26 Mar 2026, 16:35:16 UTC
Prior SEC filing
23 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Eun Young Lee

Key filing fact

Eun Young Lee filed Form 4 for Nexentis Technologies Inc. (NXTS) on 26 Mar 2026.

Key facts

  • This page summarizes Eun Young Lee's Form 4 filing for Nexentis Technologies Inc. (NXTS).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 26 Mar 2026, 16:35.

Change

  • Previous filing in this sequence was filed on 23 Mar 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002122082 Primary reporting owner

Lee Eun Young

Relationship
10%+ Owner
Address
2302-HO-2509-DONG, 20, DONGTAN-DAERO 10-GIL, DONGTAN-GU, HWASEONG-SI, GYEONGGI-DO, KOREA, REPUBLIC OF
Signature
/s/ Eun Young Lee
Signature date
26 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NXTS transaction

Common Stock, par value $0.0001 per share

Sale

Transaction value
Shares
-127
Change %
-0.03%
Price
$1.36*
Shares after
479,524
Date
29 Jan 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.35 to $1.36, inclusive. The reporting person undertakes to provide to Nexentis Technology Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .